SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pathogenesis(pgns)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mel Spivak who wrote (131)1/12/1999 5:59:00 PM
From: Biomaven  Read Replies (1) of 228
 
Maybe traders had visions of what happened to that other "one product" biotech AGPH when its pipeline was thrown into doubt when Roche pulled out of the cancer collaboration. Smarter traders then remembered that AGPH recovered nicely, and anyhow TOBI is less uncertain a product than Viracept was then perceived to be.

Alternatively, could just have been the momentum daytraders going crazy.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News